GENE ONLINE|News &
Opinion
Blog

ADC
ADC TherapeuticsIndustry Insights
Antibody-Drug Conjugates: Connecting Drugs to Cancer Cells and Unlocking Billions in Market Opportunities
2024-11-06
Oncology Market
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
BIOSECURE ActCDMO
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Hong KongDuality Bio
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
ADC
ROR1 in Focus as a target for ADC-based treatments: Recent Developments and Industry Challenges – Part III
2024-08-07
Ranking & Reports AbbVieQ2 Report
AbbVie’s Q2 2024 Financial Highlights: Growth in Immunology, Oncology, and Neuroscience
2024-08-06
ADC
NMT Inhibitors and Next-Gen Nectin-4 ADCs a Field Ripe for Research – Part II
2024-08-01
BIO Asia-Taiwan 2024 BIO Asia-Taiwan Day 1Cell and Gene Therapy
BIO Asia-Taiwan 2024 Conference has Officially Started, With International Leaders in the Industry Gathering Despite the Storm
2024-07-25
ADC
Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I
2024-07-23
ADCFirst-in-class
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
ADCSeries A Funding
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
ADCManufacturingAstraZeneca
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Interviews
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
ChinaGlobal Events
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
MoU
Celltrion and WuXi XDC Partner to Advance ADC Development and Manufacturing
2024-01-26
1 2 3
LATEST
Wendy Short Bartie Repositions Bristol Myers Squibb Corporate Affairs to Integrate Patient Advocacy and Healthcare Access
2026-09-14
Wendy Short Bartie Restructures Bristol Myers Squibb Corporate Affairs to Link Reputation with Business Performance
2026-09-14
Wendy Short Bartie Integrates Patient Advocacy and Public Trust into Bristol Myers Squibb Business Strategy
2026-09-14
Mycenax Teams Up with Global Partners to Expedite R&D and Market Launch of Next-Generation ADCs
2026-09-14
Chinese Bispecific Antibody Tops Keytruda in First Head-to-Head OS Win; SMA Muscle-Strengthening Therapy Approved, B7-H3 ADC Shows Promise
2026-09-14
GO PRIME
FDA Approves Bayer’s Sevabertinib as First-Line Treatment for Adults Living with HER2-Mutant Lung Cancer
2026-09-14
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
READ MORE
EVENT
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
2026-10-27
ESGCT 2026 (Gene & Cell Therapy)
Hamburg, Germany
SEE MORE
Scroll to Top